Synapticure Company Research Report

Company Overview

Name

Synapticure

Mission

To provide affordable and equitable access to personalized and comprehensive care for all individuals with neurodegenerative diseases. Synapticure focuses on expert virtual neurology and behavioral health care.

Founded

Founded in 2022 by Brian Wallach and Sandra Abrevaya.

Key People

Brian Wallach, JD: Co-Founder, Board Co-Chair

Sandra Abrevaya, JD: Co-Founder, Chief Executive Officer

Joe Leinbach: President & COO

Peter Wallach, MBA: Co-Founder, Chief Financial Officer, Board Member

Eric Anderson, MD PhD MBA FAAN: Chief Medical Officer

Headquarters

2045 W Grand Ave Ste B, Chicago, IL 60612

Number of Employees

No specific number of employees mentioned.

Revenue

No information is available.

Known For

Synapticure is known for its innovative approach to telehealth services for neurodegenerative diseases, including ALS, Parkinson's, Huntington's, Alzheimer's, and other dementias. The company emphasizes wraparound care coordination and compassionate support for patients and caregivers.

Products

Offerings

Synapticure offers virtual care services for various neurodegenerative disorders:

Cognitive Care: Specialized care for Alzheimer’s and other dementias.

Movement Care: Dedicated services for Parkinson’s, Huntington’s, and other movement disorders.

Neuromuscular Care: Focused care for ALS, PBP & PLS.

High-Level Descriptions and Key Features

1. Instant Access to Expert Neurologists

24/7 support for patients and caregivers.

Quick consultation scheduling, reducing the average wait time from 4-6 months.

2. Cutting-Edge Treatment & Trials

Access to emerging therapies and clinical trials.

Expert guidance on the latest scientific developments in neurodegenerative care.

3. Comprehensive Care Coordination

Each patient is assigned a personal care navigator.

Coordination of all aspects of care, including behavioral health support.

4. Telehealth Platform

Virtual care services available in all 50 states.

Accepts most insurance plans, ensuring broad accessibility.

No other specific product names or detailed features are provided in the data.

Recent Developments

In August 2024, Synapticure partnered with Pearl Health to offer enhanced dementia care under Medicare’s GUIDE program, aiming to improve patient and caregiver support.

In April 2024, Synapticure joined forces with the ALS Association to expand telehealth services for ALS patients nationwide.

In September 2023, Joe Leinbach was appointed as Chief Operating Officer as Synapticure expanded its neurological service coverage.

New Products Launched

No specific new products are mentioned in the data provided.

New Features Added to Existing Products

No specific new features for existing products are mentioned in the data provided.

New Partnerships

Pearl Health Partnership (August 2024): To democratize access to high-quality dementia care.

ALS Association Partnership (April 2024): Enhancing telehealth access for ALS patients.

This structured report provides a comprehensive overview of Synapticure and its focus on transforming care for neurodegenerative conditions. The company is committed to patient-centered care through innovative telehealth solutions, expert guidance, and extensive partnership networks.